• miR-18a–ALOXE3 Control of GBM Ferroptosis

  2026-09-09

  The reference study identifies a miR-18a/ALOXE3 regulatory axis that links ferroptosis resistance with enhanced migration in glioblastoma. Its integrated cell, biochemical, and orthotopic mouse experiments suggest that lipid-oxidation biology is both a survival mechanism and a motility regulator in GBM, while also defining important questions for translating p53-related findings into cancer research.

• Milk-Derived EVs in Intestinal Stem Cell Models

  2026-09-09

  Wang et al. developed porcine intestinal stem cell models that distinguish how milk-derived extracellular vesicles access epithelial surfaces in different intestinal regions and organoid orientations. Their findings connect apical accessibility, endocytosis-sensitive uptake, and colon stem-cell responses, providing a physiologically relevant framework for intracellular trafficking research.

• Berbamine hydrochloride in Ferroptosis Research

  2026-09-08

  Use Berbamine hydrochloride as a practical pharmacological probe for linking STAT3, NF-κB, calcium homeostasis, and ferroptosis-associated phenotypes. This workflow combines dose-response testing in KU812 and HepG2 models with orthogonal viability, lipid-peroxidation, iron, and pathway assays.

• H-89 and the PKA–Metabolism Axis in Bone

  2026-09-08

  Wnt-driven bone formation depends on more than transcriptional activation: it also requires metabolic rewiring through a Ca2+-PKA-GFAT1–O-GlcNAcylation axis. This thought-leadership article explains how H-89, a cAMP-dependent protein kinase inhibitor, can help translational researchers test the PKA contribution while preserving appropriate controls, orthogonal validation, and realistic expectations for preclinical interpretation.

• WRN Loss, p53/PUMA, and MSI Colorectal Cancer

  2026-09-07

  This PNAS study explains why mismatch repair-deficient, microsatellite-instability colorectal cancer cells depend on Werner helicase: WRN loss activates a p53/PUMA apoptotic program. Genetic rescue experiments, pharmacological inhibition, xenografts, and patient-derived models support WRN as a therapeutic vulnerability, particularly in p53-wildtype MSI tumors.

• ATS-9R: Reliable Adipose Gene Delivery

  2026-09-07

  This scenario-driven guide explains how ATS-9R (Adipocyte-targeting sequence-9-arginine), SKU C8721, can improve experimental control in adipose-tissue gene delivery, viability, proliferation, and cytotoxicity workflows. It connects Prohibitin-mediated targeting with practical complexation parameters, assay controls, data interpretation, and evidence-based product selection.

• Renal OCT2/MATE1 Inhibition by 5-HT3 Antagonists

  2026-09-05

  George and colleagues established a comparative in vitro framework for testing five antiemetic 5-HT3 antagonists against the renal organic cation transporters OCT2 and MATE1. The results identify transporter-dependent differences in inhibitory potency and support closer evaluation of renal drug–drug interaction mechanisms involving cationic medicines.

• SB 431542: Selective ALK5 Inhibitor Guide

  2026-09-04

  SB 431542 is an ATP-competitive ALK5 inhibitor that suppresses TGF-β receptor signaling through Smad2 phosphorylation inhibition. Its ALK4 and ALK7 activity requires controlled experimental interpretation in fibrosis, glioma, stem-cell, and anti-tumor immunology research.

• TCEP Hydrochloride for Capture-and-Release Assays

  2026-09-04

  TCEP hydrochloride converts controlled disulfide cleavage into a practical tool for protein preparation, linker-release experiments, and assay optimization. Its water solubility and thiol-free handling make it a useful candidate for adapting capture-and-release lateral flow workflows, provided residual reductant and antibody integrity are carefully controlled.

• CCCP Mitochondrial Morphology Workflow Guide

  2026-09-03

  CCCP provides a controllable way to impose mitochondrial proton gradient disruption and test how living cells remodel their mitochondrial networks. This guide translates the urine-derived stem cell imaging strategy from a recent Alzheimer’s disease study into practical perturbation, imaging, AI-analysis, and troubleshooting workflows.

• Quercetin in LPS-Induced Depression: NLRP3 Findings

  2026-09-03

  A pre-proof study reports that quercetin improves depressive-like behavior and memory deficits in an LPS-induced mouse model while suppressing hippocampal NLRP3-associated neuroinflammation. Its main contribution is the integration of mood, cognition, microglial, and inflammasome-related endpoints, although translation to clinical antidepressant therapy remains preliminary.

• SARS-CoV-2 N Protein Sequesters GADD34 in Atypical Foci

  2026-09-02

  The 2024 Molecules study identifies a distinct SARS-CoV-2 immune-evasion mechanism in which nucleocapsid protein redirects GADD34 mRNA into atypical G3BP1-positive foci. This sequestration reduces GADD34 expression, impairs IRF3 nuclear localization and weakens interferon production, providing a mechanistic framework for studying stress-granule-dependent viral pathogenesis.

• Targeted SPP1 Inhibition in Tumor-Associated Macrophages

  2026-09-02

  The reference study develops a phenotypic screening and delivery strategy to reduce SPP1 expression in tumor-associated macrophages rather than treating SPP1 only as a prognostic marker. Its lead compound, CANDI460, was incorporated into a TAM-avid polymeric nanoconstruct and produced SPP1 suppression and tumor remission across murine models, providing a framework for macrophage-directed cancer research.

• Vitamin C and Cochlear Cell Senescence

  2026-09-01

  A 2024 Molecular Biology Reports study shows that Vitamin C attenuates D-galactose-induced senescence in HEI-OC1 cochlear hair cells. The findings connect reduced oxidative stress with suppression of NF-κB activation, providing a mechanistic basis for investigating ascorbic acid in age-related hearing loss models while highlighting the limits of cell-based evidence.

• Geneticin, G418 Sulfate in Translational Design

  2026-09-01

  Geneticin is more than a routine selection reagent: its translation-level mechanism can shape model quality, assay interpretation, and antiviral study design. This thought-leadership guide connects G418 Sulfate workflows with the mechanistic lessons of CLK2-driven platinum resistance in ovarian cancer while defining the boundaries of what the evidence supports.

7997 records 1/534 page Next 12345 下5页 Last page